Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Moderna

Stock Market Today: Stocks Rise in Choppy Day for Markets

Moderna was the worst S&P 500 stock today after the vaccine maker slashed its R&D budget.

Kiplinger

Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.

Kiplinger

Dow Jones Rallies Late As Nasdaq, Nvidia Clear Important Chart Levels (Live Coverage)

Indexes were mixed in the stock market today after inflation showed signs of easing. Nvidia cleared a key level after analysts made it a top pick.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna Crashes After Slashing Its R&D Budget, Issuing Light Guidance

Moderna stock crashed Thursday after the Covid vaccine maker slashed its R&D budget and issued a light sales view.

Investors Business Daily

Is Moderna Stock Underperforming the Nasdaq?

While Moderna has underperformed the broader Nasdaq index in 2024, analysts are reasonably bullish about the stock's potential.

Barchart

Stocks Finish Higher on Support From Chip Stock Rebound

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +1.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.30%. Stocks on Monday posted moderate gains on some dip buying following last Friday’s sharp...

Barchart

New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots

COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it’s estimated COVID shots have saved more than 1.4 million lives in the World Health Organization’s (WHO) European region alone since their introduction in December 2020.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Stocks Climb on Strength in Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.95%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. Stocks today are moderately higher, recovering some of last Friday’s sharp sell-off on some...

Barchart

Stocks Move Higher on Strength in Chip Stocks and Positive Corporate News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.11%. Stocks today are moderately higher, recovering some of last Friday’s sharp sell-off as chip...

Barchart

Moderna MRNA Mpox Vaccine Shows Promise In Animal Study

An experimental Moderna mRNA vaccine for mpox has demonstrated greater effectiveness than current shots in reducing disease symptoms and duration, according to an animal study published in the journal Cell on Wednesday.

International Business Times

New COVID vaccines are here. What to know about 2024–25 shots as summer surge continues

Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.

Fortune

A new Covid vaccine is available. Here’s why some people might not want it right away

Updated Covid vaccines were approved by the FDA earlier this month

The Independent UK

FDA Approves Updated Covid-19 Vaccines From Moderna And Pfizer

FDA approves updated Covid-19 vaccines from Moderna and Pfizer/BioNTech to enhance protection against current variants and combat rising cases.

Top News

FDA Approves Updated COVID-19 Vaccines Targeting Variants

FDA-approved updated COVID-19 vaccines crucial for protection against new strains. Get vaccinated promptly to safeguard public health.

Roll Call

FDA greenlights updated COVID shots, prepares for fall rollout - Roll Call

The FDA approved updated COVID-19 vaccines for the 2024-25 season, preparing for an expected spike in cases this fall and winter.

Investors Business Daily

Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell In December 2024?

Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell in December 2024?

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Infectious diseases spike when kids return to school − here’s what you can do about it

Ready or not, back-to-school season is here, and kids will be bringing home more than homework. They’ll be carrying germs, too.

Investors Business Daily

Analysts Predict 9 Beaten-Down Stocks Will Soar Big Time

What's the best part of a big S&P 500 sell-off? It can open up new ways to make money.

Investors Business Daily

Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again.

Moderna stock, which lost 27% of its value over two days, tumbled again Monday on a rare downgrade amid uncertainty for its vaccines.

Fortune

Top recruiters and CHROs from Moderna, Hilton, PwC say these are the 6 ways to stand out in a cooling job market

Job seekers need to hone a personal brand, upskill themselves, and stay resilient.

Investors Business Daily

7 Stocks' Revenue Totally Smashes All Expectations

It may be earnings season for the S&P 500 — but revenue is on top of many investors' minds.

Investors Business Daily

Moderna Slashes Its Outlook On 'Very Low' European Sales Despite Quarterly Beat

Moderna cut its outlook early Thursday despite delivering nearly double strong quarterly sales. Moderna stock tumbled.

Barchart

Moderna's Quarterly Earnings Preview: What You Need to Know

Moderna is expected to release its fiscal second-quarter earnings next month, and analysts project a narrower loss.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

842 stories

PwC

693 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.